Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients

Fig. 1

A Paracancer and cancer samples from a PC patient as confirmed by H&E staining. B Paracancer and cancer samples from a PC as assessed by immunofluorescence (IF) staining to select appropriate ROIs. Green for CK staining, red for CD45 staining, and blue for Syto 13 staining. C The selected ROIs shown in the paracancer sample. D The selected ROIs shown in the cancer sample

Back to article page

Molecular Medicine

ISSN: 1528-3658